文献速递神经介入DSA

后循环卒中血管内治疗反应的预测因素

Predictors of response to endovascular treatment of posterior circulation stroke.
PubMed 文献 · Eur J Radiol · 2019-05-02

研究连续纳入47例急性后循环卒中并接受血管内治疗的患者,评估临床与血管造影因素与90天良好预后(改良Rankin评分0-3分)的关系。多因素分析显示年龄<70岁(OR=6.20,95%CI 1.52-25.47,p=0.01)和无颅内动脉粥样硬化(OR=6.45,95%CI 1.09-38.24,p=0.04)与良好预后独立相关。作者认为治疗前判断有无颅内动脉粥样硬化有助于患者管理,无颅内动脉粥样硬化可能作为未来试验中血管内治疗的正向选择标准。

要点

  • 年龄<70岁与良好预后独立相关(OR=6.20,95%CI 1.52-25.47,p=0.01)。
  • 无颅内动脉粥样硬化与良好预后独立相关(OR=6.45,95%CI 1.09-38.24,p=0.04)。
  • 治疗前判断有无颅内动脉粥样硬化可能有助于后循环卒中患者管理。

核心结论

  • 年龄<70岁和无颅内动脉粥样硬化是后循环卒中血管内治疗后良好预后的独立预测因素。

研究设计与样本

  • 单中心连续病例研究,纳入2015年1月至2017年12月在本综合卒中中心接受血管内治疗的急性后循环卒中患者47例,采用改良Rankin评分0-3分定义90天良好预后,颅内动脉粥样硬化依据血管内治疗中记录的局限性狭窄确定。

诊断标准与关键数值

  • 良好预后定义为90天改良Rankin评分0-3分;颅内动脉粥样硬化依据血管内治疗中记录的局限性狭窄确定;多因素分析中年龄<70岁OR=6.20(95%CI 1.52-25.47,p=0.01),无颅内动脉粥样硬化OR=6.45(95%CI 1.09-38.24,p=0.04)。

临床应用与阅片要点

  • 作者认为治疗前判断有无颅内动脉粥样硬化可辅助后循环卒中患者的管理;无颅内动脉粥样硬化可能作为未来试验中血管内治疗的正向选择标准;有颅内动脉粥样硬化可作为未来研究新治疗方案时的选择工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Endovascular treatment is considered a reasonable approach for patients with acute posterior circulation stroke, but it remains uncertain which patients will benefit the most from it.

OBJECTIVE: To find independent clinical and angiographic predictors of outcome after endovascular treatment for posterior circulation stroke.

METHODS: We evaluated consecutive patients with acute posterior circulation stroke who underwent endovascular treatment in our comprehensive stroke center from January 2015 to December 2017. Good outcome was defined as a modified Rankin score of 0-3 at 90 days. Intracranial atheromatous disease was established on focal stenosis recorded during endovascular treatment. Associations were sought between a good outcome and clinical and angiographic factors. Adjusted logistic regression models were used to define independent outcome predictors.

RESULTS: Forty-seven consecutive patients were included: mean age 70.9 ± 12.1 years, median admission NIHSS score, 16 (IQR: 8-30). On univariate analysis, age (p = 0.01), smoking (p = 0.04), hypertension (p = 0.03), successful reperfusion (p = 0.04), presence of extracranial atherosclerosis (p = 0.02), and absence of atherosclerosis (p = 0.03) were significantly associated with a good outcome. On multivariate analysis, age <70 years (odds ratio = 6.20, 95%CI 1.52-25.47, p = 0.01) and absence of intracranial atherosclerosis (odds ratio = 6.45, 95% CI 1.09-38.24, p = 0.04) were independently associated with a good outcome.

CONCLUSIONS: Pretreatment determination of the presence or absence of intracranial atherosclerosis can aid management of posterior circulation stroke patients. The absence of intracranial atherosclerosis may have value as a positive selection criterion for endovascular treatment in future trials. The presence of intracranial atherosclerosis could be used as a selection tool in future studies investigating new treatment protocols for this population.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Gramegna LL, Requena M, Dinia L, et al. Predictors of response to endovascular treatment of posterior circulation stroke. Eur J Radiol. 2019. PMID: 31153569. doi:10.1016/j.ejrad.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。